Today is: April 17, 2011

Evaluate Your Case Today







Calcagno & Associates

900 South Avenue, 3rd Floor
Staten Island, NY, 10314
Phone: 1-800-WE-FIGHT
             (718) 568-3585


By appointment only

Battery Place
New York, NY, 10004
Phone: (800) 933-4448

Grand Concourse Bronx, NY, 10451 Phone: (718) 933-4448

Bay Parkway Brooklyn, NY, 11214 Phone: (800) 487-6837


Name (First & Last)
DOB (Victims Date of Birth)

Phone

Email Address

Address

City

State

ZipCode

Message about your case

Are You Taking Raptiva for Psoriasis? You Are At Risk of a Deadly Brain Infection

Raptiva, a Genentech drug used for the treatment of moderate to severe psoriasis, is being pulled from the United States market after it was linked to reports of a rare but most often potentially deadly brain infection called progressive multifocal leukoencephalopathy (PML).

On April 8, 2009, Genentech announced that it was suspending sales of Raptiva in the U.S., due to reports of people taking the drug developing PML. The company advised physicians to immediately stop prescribing Raptiva for new psoriasis patients and to contact patients currently taking the drug to determine the best course of action for treatment. The company’s phased withdrawal of the drug was expected to culminate by June 2009, when Raptiva would no longer be available. As many as 2,000 Americans are taking Raptiva.

The withdrawal of Raptiva from the U.S. market follows the February 2009 announcement by the Food and Drug Administration that it was investigating recent reports of Raptiva causing three deaths from PML and other severe cases of the disease in people taking the drug.

Psoriasis is a chronic immune-system disease which causes red, thick patches to develop on the skin. It is most common in people with diabetes, obesity, and heart disease and affects up to 7.5 million people in the United States.

If you or a loved one has developed PML or suffered another injury while taking Raptiva, you may be entitled to financial compensation for your medical bills, pain and suffering, and other damages. If a love one has died as the result of taking Raptiva, you and your loved ones may qualify for damages to compensate you for the wrongful death. Our law firm is available 24/7 to answer any Raptiva claim questions you may have. Contact us today for a free, no obligation, Raptiva Brain Infection legal consultation by completing the case evaluation form on the right side of this page or by calling 1-800-WE-FIGHT (1-800-933-4448).

What is PML?

PML is a viral disease of the brain which most often occurs in people who are undergoing chronic corticosteroid or immunosuppressive therapy, have had an organ transplant, or have lymphoma, Hodgkin’s disease, sarcoidosis, or other cancers. PML is more common in people with acquired immune deficiency syndrome (AIDS). Up to five percent of people with AIDS will develop PML.

FDA Issues Warnings About Raptiva

In recent years, Raptiva has been the subject of several FDA warnings and advisories. In October 2008, the FDA required Genentech to add a Black Box Warning – the strongest warning the agency can issue — on Raptiva’s packaging. The new warning was designed to alert physicians and users of the increased risks of PML from taking Raptiva. The FDA also ordered the drug’s maker to develop a medication guide and other literature for the drug’s packaging to address the risks of PML.

Free Legal Consultation

If you or a loved one developed life-threatening PML or another injury after taking Raptiva, you may have a right to be financially compensated. The drug is approved for the treatment of psoriasis, a chronic skin condition which affects millions of Americans. Our attorneys can evaluate your injuries and advise you about whether you qualify to be compensated for your medical bills, pain and suffering, lost wages, and other damages. Our law firm is available 24/7 to answer any Raptiva Injury questions you may have. Contact us today for a free, no obligation, Raptiva legal consultation by completing the case evaluation form on the right side of this page or by calling 1-800-WE-FIGHT (1-800-933-4448).

Return to Defective Drugs Listing

 

Keywords | Articles | Locations | Coupons |